Allegra Orthopaedics Limited advised that sales revenues for the full year of 2020 from its Orthopaedic Division are expected to increase by 20% to 25% compared with sales revenues achieved in 2019. Net profit/(loss) for the company is only expected to improve marginally compared with 2019. This is due to increased net operating costs of the Company's Innovation division, which continues with planned development activities to commercialise the cervical spinal cage implant.